An Evaluation of the Effectiveness of Local Anesthetics Used During Intravenous Catheter Insertion
NCT ID: NCT02162680
Last Updated: 2014-08-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
99 participants
INTERVENTIONAL
2010-03-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Local Anesthetics for Pain Reduction Prior to IV Line Placement
NCT01759459
Bacteriostatic Normal Saline Versus Lidocaine for Intradermal Anesthesia
NCT04495868
The Effect of Lidocaine and Benzocaine on Pain and Injection Satisfaction in Peripheral Intravenous Catheter Application
NCT04859738
Effectiveness of 10% Lidocaine on Relieving Pain Caused by Intravenous Intubation
NCT07212192
Effects of Topical Lidocaine and Benzocaine on Pain Level and Injection Satisfaction
NCT07242157
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lidocaine
1% lidocaine intradermal injection
1% lidocaine
bacteriostatic normal saline (BNS)
bacteriostatic normal saline (BNS) injection
bacteriostatic normal saline (BNS)
no local anesthetic
usual care practice of no local anesthetic administration
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1% lidocaine
bacteriostatic normal saline (BNS)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to a general medical or surgical unit at Durham Regional Hospital (DRH)
* have a physician's order for an IV
* are able to speak, read and understand English
* referred to the Vascular Access Specialty Team (VAST) at DRH for IV catheterization
Exclusion Criteria
* history of a psychological disorder, as determined from the patient's chart;
* history of peripheral neuropathy, as determined by patient's chart;
* history of IV drug abuse, as determined from the patient's chart;
* decreased sensation in the arm or hands, as reported in the chart or by the patient;
* patient disorientation or confusion (i.e., unable to state person, place, time or unable to comprehend instructions for completing Visual Analog Scale);
* a known allergy to lidocaine or benzyl alcohol as determined from the patient's chart;
* veins that cannot be palpated and are difficult to visualize by VAST nurses;
* pregnancy;
* an order for the emergency insertion of an IV by the patient's doctor or assigned nurse;
* an IV insertion that requires the use of a catheter gauged 18 or larger
* severe vision impairment, as determined by the patient's inability to read the Visual Analogue Scale
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julia Aucoin, DNS, RN
Role: PRINCIPAL_INVESTIGATOR
Duke Health
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00015861
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.